The GEO Group, Inc. — Q2 2023 Form 10-Q
Reporting period: Three and six months ended June 30, 2023; comparisons are with the corresponding 2022 periods. GEO operates secure facilities, electronic monitoring and supervision, reentry services, and international services. At June 30, 2023, it reported approximately 82,000 beds at 102 facilities, including idle facilities, and community-supervision services for more than 400,000 people on average.
Financial performance and liquidity
| Metric | Q2 2023 | Q2 2022 | Six months 2023 | Six months 2022 |
|---|---|---|---|---|
| Revenue | $593.9 million | $588.2 million | $1,202.1 million | $1,139.4 million |
| Operating income | $92.4 million | $95.1 million | $185.0 million | $176.6 million |
| Operating margin | 15.6% | 16.2% | 15.4% | 15.5% |
| Net income attributable to GEO | $29.6 million | $53.7 million | $57.6 million | $91.9 million |
| Diluted EPS | $0.20 | $0.37 | $0.39 | $0.63 |
Q2 revenue increased 1.0%, while operating income decreased 2.8% and GEO-attributable net income fell 45.0%. For the first half, revenue rose 5.5% and operating income rose 4.8%, but attributable net income declined 37.4%. Higher interest expense was a major drag: $55.0 million in Q2 versus $33.2 million, and $109.3 million for the half versus $64.8 million. The company attributed the increase to higher rates on its debt, rising SOFR/LIBOR and debt-issuance-cost amortization. Q2 interest income also declined, primarily following the 2022 Ravenhall sale.
Q2 operating expenses increased 4.0% to $428.1 million, or 72.1% of revenue versus 70.0%. For the first half, operating expenses rose 8.1% to $861.6 million, or 71.7% of revenue versus 69.9%. GEO cited labor, medical and other variable costs, including costs associated with higher populations at some facilities. General and administrative expense declined 15.4% in Q2 and 6.2% for the half.
Six-month operating cash flow was $113.0 million, down from $172.0 million. Investing used $32.3 million, including $31.6 million of capital expenditures; financing used $103.6 million, principally for $106.1 million of debt payments. Cash and cash equivalents were $48.7 million at June 30, down from $95.1 million at year-end; cash, cash equivalents and restricted cash totaled $118.8 million. Current assets were $452.0 million and current liabilities $347.2 million.
Total debt was $1.876 billion, down from $1.979 billion at December 31, 2022. Long-term debt, net, was $1.846 billion. GEO reported a 12.01% weighted-average rate on Exchange Credit Agreement borrowings, no revolver borrowings, and approximately $188.1 million of additional revolver capacity after letters of credit. It was in compliance with debt covenants at June 30. Management said cash on hand, operating cash flow and credit availability should support 2023 capital requirements; planned active capital projects total about $53.3 million, with $20.4 million remaining to spend in 2023.
Changes by business and notable developments
- U.S. Secure Services: Q2 revenue rose 5.4% to $372.5 million, but segment operating income fell to $67.1 million from $72.8 million. Revenue benefited from contract modifications, rates and occupancy, partly offset by facility ramp-downs and terminations. U.S. facility occupancy excluding idle facilities was 86.6% in Q2 and 86.7% for the first half, below the respective 2022 levels of 88.3% and 88.0%.
- Electronic Monitoring and Supervision: Q2 revenue declined 11.1% to $108.0 million as average ISAP participant counts fell; first-half revenue increased 14.9% to $240.7 million, reflecting participant growth earlier in the period.
- Reentry Services: Q2 revenue rose 2.9% to $67.6 million; segment operating income fell to $10.2 million from $14.2 million as costs outpaced revenue. New day-reporting contracts and higher center census contributed to growth.
- International Services: Q2 revenue decreased 3.9% to $45.7 million, primarily from foreign-exchange movements. First-half revenue fell 7.2% to $91.1 million.
- In April, GEO signed a 66-month lease for the previously idle Great Plains Correctional Facility, expected to generate about $8.4 million in annualized revenue. GEO’s Australian health-services contract began July 1, 2023 and is expected to add approximately AUD47.5 million, or $32.1 million, in annualized revenue. The company also reported a ten-year renewal of its GEOAmey secure-transportation contract in the UK.
Outlook, risks and contingencies
- Management estimated a 2023 annual effective tax rate of approximately 27%–30%, excluding discrete items. The filing does not provide consolidated revenue or earnings guidance.
- GEO said it was encouraged by potential growth opportunities but cautioned that government budget constraints, changes in public-private partnership policies, contract loss or non-renewal, lower occupancy, and cost inflation could adversely affect results. It expects labor, medical, food, utility and insurance costs, as well as start-up costs, to pressure operating expenses.
- Nine idle facilities with 10,221 vacant beds had a combined net book value of $261.1 million. GEO estimated 2023 carrying costs of $30.9 million, including $15.8 million of depreciation, and stated it had no firm activation commitments. The company’s illustrative estimate if all nine were activated—approximately $300 million annualized revenue and $0.30–$0.35 annualized EPS increase—is conditional, not a forecast.
- The company has three facilities under direct USMS contracts; related option periods expire between September 2023 and February 2028. They represented about 6% of first-half 2023 revenue. GEO no longer has BOP secure-facility contracts. Washington stated it would not enforce HB 1090 against GEO’s Northwest ICE Processing Center, and a permanent injunction against California’s AB-32 was entered in GEO’s favor.
- Immigration-detainee litigation remains a significant uncertainty. Washington cases resulted in a combined $23.2 million judgment plus $12.7 million in fees, costs and prejudgment interest; enforcement is stayed pending appeal, with state-law questions before the Washington Supreme Court. Related cases in Colorado and California also remain pending. GEO said it had not accrued losses for the described detainee lawsuits where losses were not considered probable. A shareholder class-action settlement was reached, with final-approval hearing scheduled for November 2023; related derivative cases are stayed.
- Interest-rate exposure is material: GEO estimated that a 1-percentage-point increase in rates applicable to its Exchange Credit Facility would add about $10 million to annual interest expense. Its Exchange Credit Agreement includes leverage and interest-coverage covenants. GEO also disclosed an Australian operating-performance guarantee of about $35.2 million and other Australian performance-guarantee letters of credit totaling $10.9 million.
Investor verification priorities
- Track debt repayments, refinancing needs and interest costs, particularly given the reported 12.01% weighted-average Exchange Credit Agreement rate and 2024–2026 debt maturities.
- Assess whether operating cash flow can sustain debt reduction and planned capital spending as cash balances decline.
- Monitor ISAP participant trends, facility occupancy, contract renewals and activation prospects for idle facilities.
- Follow the Washington detainee-litigation appeal and other labor-program cases, including potential financial exposure and any change in accruals.
- Check whether the anticipated revenue contribution from the Australian health-services contract and Great Plains lease is realized, and whether cost inflation continues to pressure margins.